Delivery Order SPE2DB22D3004-SPE2DB25FSH23
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of OPZELURA 1.5% Cream in 60-gram quantities, valued at $4,813.05. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement. The order is scheduled for ultimate completion by July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,258.72 for OPZELURA 1.5% Cream 60GM on August 14, 2025, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single pharmaceutical product delivery under the company's larger contracting...
- The Defense Logistics Agency awarded a delivery order valued at $2,620.90 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on August 12, 2025, with completion expected by August 13, 2025. This is a firm fixed-price, non-competitive delivery order under the company's existing contract vehicle. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,875.38 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60GM) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,760.29 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream (60gm), a topical pharmaceutical product. This firm fixed-price, non-set-aside contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,503.51 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram quantities under a firm fixed-price contract. The award was made on August 28, 2025, with an ultimate completion date of August 29, 2025, with no set-aside designation applied. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,755.69 to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram units. This firm fixed-price, competitive contract (no set-aside designation) was executed on August 14, 2025, with an ultimate completion date of August 15, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $16,474.15 delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in 60-gram units under a firm fixed-price contract. This non-set-aside delivery order was competitively awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram quantity, valued at $5,766.81. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award. The order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Opzelura 1.5% Cream in a 60-gram format, with a ceiling value of $2,046.89. This competitively awarded, firm fixed-price contract is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The delivery order carries...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FSH23Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OPZELURA 1.5% Cream in a 60-gram unit on September 4, 2025, with a ceiling value of $2,171.95. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of September 5, 2025. This delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle. This award is issued under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC serves as the primary mechanism for the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contracting demonstrates significant capability in fulfilling diverse medical procurement requirements for defense and veteran healthcare systems, with extensive experience delivering specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/4/25 |